| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.36 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |